Slotnik Capital’s Terns Pharmaceuticals TERN Stock Holding History

Slotnik Capital’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-420,700	Closed	-$22.2M	–	39
2026 Q1	$22.2M	Buy	+420,700	New	+$17.3M	6.49%	4

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Slotnik Capital's TERN Position: Q2 2026 in Review

Slotnik Capital sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 420,700 shares — an estimated $22.2M sold.

Slotnik Capital first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $22.2M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Slotnik Capital reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Slotnik Capital sold 420,700 Terns Pharmaceuticals shares in Q2 2026, an estimated $22.2M.
Slotnik Capital first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Slotnik Capital's Terns Pharmaceuticals position peaked at $22.2M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Slotnik Capital's 13F filing for Q2 2026, filed 13 Aug 2026.